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Abstract
Background: Conjugation of small ubiquitin-related modifiers (SUMOs) is a frequent post-translational modification of 
proteins. SUMOs can also temporally associate with protein-targets via SUMO binding motifs (SBMs). Protein 
sumoylation has been identified as an important regulatory mechanism especially in the regulation of transcription 
and the maintenance of genome stability. The precise molecular mechanisms by which SUMO conjugation and 
association act are, however, not understood.
Findings: Using NMR spectroscopy and protein-DNA cross-linking experiments, we demonstrate here that SUMO-1 
can specifically interact with dsDNA in a sequence-independent fashion. We also show that SUMO-1 binding to DNA 
can compete with other protein-DNA interactions at the example of the regulatory domain of Thymine-DNA 
Glycosylase and, based on these competition studies, estimate the DNA binding constant of SUMO1 in the range 1 
mM.
Conclusion: This finding provides an important insight into how SUMO-1 might exert its activity. SUMO-1 might play a 
general role in destabilizing DNA bound protein complexes thereby operating in a bottle-opener way of fashion, 
explaining its pivotal role in regulating the activity of many central transcription and DNA repair complexes.
Background
Ubiquitin and small ubiquitin-like modifiers (SUMOs)
form a family of structurally related proteins that often
become covalently attached to other cellular factors. This
post-translational modification of proteins, usually on
lysine residues, with ubiquitin and SUMOs changes the
functional properties of their targets [1-15]. Both, the
regulation of the target's enzymatic activity and the mod-
ification of interaction patterns with third partners such
as proteins and DNA have been described. Thereby,
sumoylation apparently also provides a means to recruit
SUMO interacting proteins via their SUMO binding
m o t i f s  ( S B M s )  t o  t h e  s u m o y l a t e d  t a r g e t  [ 1 6 ] .  F u r t h e r -
more, sumoylation and SUMO association have been
found to influence other post-translational modifications
such as phosphorylation. Sumoylation is an energy-
dependent process carried out by a dedicated enzymatic
machinery which is similar in composition and activity to
the ubiquitination apparatus [2-7,9,10]. SUMO-specific
proteases (SENPs) can reverse the process of sumoyla-
tion. Sumoylation has an essential role in most organ-
isms. Deletion or inactivation of SUMOs or enzymes
involved in the sumoylation process lead to severe growth
defects in yeast or embryonic lethality in mice [2,3,8]. It is
likely that lethality is the effect of deregulation of many
different activities rather than only a single essential func-
tion given the variety of processes that involve sumoyla-
tion and SUMO binding [1-15].
Amongst the most prominent pathways which have
b e e n  i d e n t i f i e d  t o  b e  r e g u l a t e d  b y  s u m o y l a t i o n  a n d
SUMO non-covalent interactions are transcriptional reg-
ulation and genome maintenance pathways [2,12-15,17].
Known targets for sumoylation include the transcription
factors p53, HSF1, and STAT1. Transcription associated
proteins such as the histone deacetylases (HDACs), or the
co-repressors Daxx and CtBP are also found to be modi-
fied by SUMOs [14,15]. Particularly interesting is the role
of sumolyation in the modification of the promyelocytic
leukemia protein (PML) and the oncogenic chromosomal
t15:17 translocation product PML-RARα, as SUMO
modification and association has been shown to exert
major effects on nuclear protein localization, stability,
and activity. Similar effects have been observed on other
transcription factors [18,19]. As a general theme, sumoy-
lation of transcription associated proteins seems to have a
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negative effect on the promoter activity of target genes
[20-23]. SUMO, by providing additional protein-protein
interaction surfaces, predominantly recruits negative reg-
ulators of transcription, or sequesters transcription fac-
tors by an unknown mechanism into sub-nuclear
domains devoid of transcription activity [2-15,20-23].
Another group of cellular pathways heavily influenced
by sumoylation and SUMO binding are the genome
maintenance systems [17]. Genetic manipulations in
yeast have allowed to uncover a wealth of genome main-
tenance defects upon inactivation of different compo-
nents of the SUMO system essentially involving all
aspects of DNA damage response, replication, and chro-
mosomal stability [2-15]. The importance of regulation of
genome maintenance pathways by sumoylation has been
confirmed for higher eukaryotes, albeit neither the tar-
gets nor the effects and still less the molecular mecha-
nisms involved are known [2-15].
In this context the recent finding of sumoylation and
SUMO association of Thymine-DNA Glycosylase (TDG)
and the regulatory effects that SUMO proteins exert on
this enzyme are of particular interest [24-26]. TDG is part
of the base-excision DNA repair (BER) machinery target-
ing G:U and G:T mispairs in DNA. Indeed, these mis-
matches frequently occur on double-stranded DNA after
spontaneous or catalytically-mediated hydrolysis of cyto-
sine or C5-methylated cytosine leading to uracil and thy-
mine, respectively. TDG and TDG-like activities are
crucial for both, the avoidance of point-mutations and
the maintenance of methylation patterns. SUMO conju-
gation and association have been well studied in the case
of TDG, and lead to the description of partial structures
of TDG-SUMO complexes, and important regulatory
roles of SUMO proteins in the specification of TDG
repair activity [24-26]. The fine structure analysis of the
regulatory domain of TDG [27], has thereby allowed to
better investigate the effect of SUMO-1 binding to and
SUMO-1 covalent modification of TDG [28]. During the
course of these works we made the observation that
SUMO-1 can specifically interact with DNA and compete
with other DNA binding proteins reported here.
Results and Discussion
Based on our previous fine-structure analysis of the TDG
regulatory domain (RD) dynamics of TDG [27], we
started studying also different TDG SUMO complexes in
the presence or absence of DNA using nuclear magnetic
resonance. We thereby have uncovered a competition
mechanism by which SUMO prevents or destabilizes RD
DNA interactions. Such a competition can either be
explained by a steric hindrance mechanism, or by direct
competition for DNA binding [28].
We thus investigated the ability of SUMO-1 to directly
interact with DNA. By acquiring a HSQC spectrum on
15N-labeled SUMO-1 at 20 μM in presence of 135 μM of
the same DNA substrate containing a central G:U mis-
match which had been used in the experiments leading to
the hypothesis of SUMO-1 DNA binding (5'-GCTTC-
GAGTACCUGTGGAACCTATC-3') we observe chemi-
cal shift perturbations for several SUMO-1 resonances
(Figure 1A) concerning mainly positively charged resi-
dues and their neighborhood. They encompass the K23
and K25 residues of the β1 strand, H35 of the β2 strand,
H43 of the β2/α1 loop, K45, K46 and K48 of the α1 helix,
R63 of the β4 strand and finally H75 from the β4/β5 loop
(Figure 1B, C). Importantly, other positively charged and
solvent-accessible residues such as K37, K39 in the imme-
diate vicinity, as well as K10, K19, and K20 in the N-ter-
minus of SUMO-1 are not perturbed, indicating
specificity of the observed DNA interaction with before
mentioned sites. Furthermore, the residues for which
DNA interactions are observed form a continuous patch
along the SUMO-1 surface.
Interestingly, only K25 and R63 are conserved amongst
all SUMO family members, indicating that DNA binding
activity might be restricted to SUMO-1 (Figure 2).
SUMO-1 DNA complexes can also be detected using
UV-crosslinking experiments. Figure 3A illustrates the
formation of GST-SUMO-1 DNA complexes specific to
the presence of a 65 bp double-stranded mismatch-free
DNA oligonucleotide (5'-CGGATCCCAACTCCAG-
GAAGGAAACCA AGCGATTGGTTTCCTTCCTG-
GAGTTGTTTTTCCCGGGT-3'). Free GST protein does
not interact with DNA. Note that we used GST fusion
proteins, despite their capacity to dimerize which slighly
complicates the analysis of the results (ref, Figure 3, 4), in
order to provide for a negative control and concomitant
detection with a single antibody in order to exclude
biases. Indeed, also wild-type SUMO-1 protein lacking a
GST-tag can be shown to bind the 27 bp double-stranded
DNA oligonucleotide (5'-CGGGGCCGGGGCGGGC-
CGCGCAAGCAG-3') (Figure 3B) in similar experi-
ments. As confirmed using DNaseI digestion (Figure 3C)
t h e  h i g h  m o l e c u l a r  w e i g h t  b a n d  a t t r i b u t e d  t o  G S T -
SUMO-1 DNA complexes contains DNA. DNaseI treat-
ment destabilizes GST-SUMO-1 dimer formation, which
conincides with a slight increase of GST-SUMO-1 dimer
formation upon addition of increasing amounts of dou-
ble-stranded DNA (Figure 3A). These observations can
be explained by dsDNA stabilizing the GST-SUMO-1
dimers created through homo-association via their GST
tags. A dimerization of non-tagged SUMO-1 protein is
not observed (Figure 3B). Our findings are further sub-
stantiated when an unrelated, double-stranded, 3'-NH-
AlexaFluor488®  labeled oligonucleotide (5'-AGCTTC-
GAGTACCCGTGGAACCTATCG-3'), is used in the UV-
crosslinking experiments and the reaction products are
analyzed for their fluorescence (Figure 3D). Furthermore,Eilebrecht et al. BMC Research Notes 2010, 3:146
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Figure 1 SUMO-1 DNA interaction detected using NMR. (A) Comparison of 1H projections of the 15N-1H HSQC spectra of 15N-SUMO-1 (black) 
and 15N-SUMO-1 at 20 μM with 135 μM of 25-mer double-stranded DNA containing a G:U mismatch (red). (B) SUMO-1 (PDB ID 2ASQ) ribbon repre-
sentation in grey. SUMO-1 residues implicated in DNA binding are colored as a function of their chemical shift variations: red for Δδ > 0.06 ppm and 
orange for 0.02 < Δδ < 0.06 ppm. (C) SUMO-1 solvent accessible surfaces colored as described for B.
K23 
K25 
H43 
H75 
K45 
K46 
R63 
H35 
a 
b c Eilebrecht et al. BMC Research Notes 2010, 3:146
http://www.biomedcentral.com/1756-0500/3/146
Page 4 of 7
as the sequences of the 65-mer and the 27-mer are unre-
lated and also differ from the 25-mer G:U mismatch oli-
gonucleotide used in the NMR experiments, these
experiments establish sequence independence of the
SUMO-1 DNA interaction. We then compared the rela-
tive retention of the GST-SUMO-1 complexes formed
with either the 65-mer or the 27-mer DNA strands. The
complex formed in the presence of the shorter 27 mer
dsDNA indeed migrates faster than the one correspond-
ing to the 65-mer (Figure 3E).
Figure 2 Conservation of SUMO-1 residues implicated in DNA binding amongst SUMO family members. Residues 20-80 of human SUMO-1 
are shown, the residues colored in red display chemical shift variations Δδ > 0.02 ppm when in contact with DNA. For the other SUMO family members 
only the residues at the corresponding positions are shown.
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Figure 3 UV cross-linking experiments confirm SUMO-1 DNA interaction. (A) 100 ng of GST or GST-SUMO-1 were exposed in the absence or pres-
ence of 200 ng or 500 ng of dsDNA (69-mer) to UV (312 nm, 200 W) for 10 min. After 12.5% SDS-PAGE and western-blotting protein complexes were 
detected using a GST antibody and compared to non-exposed samples ('control'). (B) 100 ng of SUMO-1 were exposed in the absence or presence of 
400 ng or 1 μg of dsDNA (27-mer) to UV (312 nm, 200 W) for 10 min. After 12.5% SDS-PAGE and western-blotting protein complexes were detected 
using a SUMO-1 antibody and compared to non-exposed samples ('control'). (C) The GST-SUMO-1 + DNA complex is sensitive to DNase treatment. 
Experiments as in A using 200 ng of dsDNA were post cross-linking and prior SDS-PAGE incubated with or without DNaseI (2 h, 37°C). (D) The high 
molecular weight bands formed by GST-SUMO-1 in the presence of DNA can also be shown to contain DNA using a fluorescent dsDNA. (E) Sequence 
independence of SUMO-1 DNA interaction is demonstrated using two different dsDNAs and detected after 10% SDS-PAGE.
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Finally, as we propose elsewhere a direct competition
between SUMO-1 and the TDG regulatory domain for
DNA binding [28], we thought to directly demonstrate
such competition. To this end we incubated the GST-
SUMO-1 DNA mixture with increasing amounts of either
untagged SUMO-1 or the human TDG N-terminus (aa1-
111), and as a control free GST. As shown in Figure 4,
both free SUMO-1 and TDG N-terminus compete with
GST-SUMO-1 for DNA binding when present in two- or
five-fold molar excess in the reaction. Free GST does not
compete with DNA complex formation. These experi-
ments do not only confirm the specificity of the SUMO-1
DNA interaction but also lend further support to the pre-
viously reported capacity of the TDG RD to bind to DNA,
and the possible competition between both entities for
DNA during TDG mediated base-excision repair.
A complex pattern of chemical shift variations was pre-
viously observed upon NMR-based titration of 15N-
labeled TDG-N with DNA exhibiting different dissocia-
tion constants related to various sites of the TDG-N pro-
tein [27,28]. Relatively low dissociation constants (about
20 μM) have been measured for the TDG-N/DNA com-
plex around K64, K83/K84/K87 and K103/K105 sites. For
the intertwining regions, a higher Kd of 150 μM was esti-
mated, and SUMO-1 competes more efficiently with
TDG-N in these latter regions for DNA binding. Based
on the ability of SUMO-1 to compete with TDG-N to
bind DNA, as observed here with both NMR and cross-
linking experiments, the dissociation constant of the
SUMO-1/DNA complex was estimated in the range of 1
mM.
Conclusion
We have this established here using NMR and UV-cross-
linking experiments that SUMO-1 possesses specific but
sequence-independent DNA binding activity. The amino-
acids involved in this interaction have been identified,
and are only weakly conserved in identity or charge
amongst the different members of the SUMO family,
indicating an important potential difference between dif-
ferent SUMO members.
More importantly, the fact that SUMO-1 can bind
DNA, and the observation that this DNA binding is in
competition with the regulatory domain of TDG, allows
to explain how SUMO-1 exerts its activity on TDG [28].
The proposed salvage mechanism, allowing the removal
of TDG from DNA after the glycosylase reaction, might
also be a general scheme of SUMO-1 action on other
DNA binding activities such as transcription factors and
co-factors or the genome maintenance proteins known to
be sumoylated or interact with SUMO-1 through SBMs
[2-23]. SUMO-1 might play a general role in destabilizing
DNA bound protein complexes thereby operating in a
bottle-opener way of fashion [18,19].
Materials and methods
Expression and purification of recombinant SUMO-1 and 
TDG N-terminus
SUMO-1 and TDG-N proteins were overexpressed in
BL21(DE3) strain as GST fusion protein. Bacteria were
grown at 37°C in M9 minimal medium reconstituted with
2 g/l glucose, 1 g/l 15N-labeled ammonium chloride, 1
mM MgSO4, MEM vitamin cocktail (Sigma) (or in LB
medium for the production of unlabeled proteins) and
100 mg/l ampicilline. Protein expression was induced
overnight at 20°C following 0.5 mM IPTG addition. Cells
were harvested and resuspended in extraction buffer
(PBS, 10% glycerol, 1% Triton X-100, 10 mM EDTA, 2
mM DTT) complemented with a protease inhibitor cock-
tail (Complete, Roche). Cell lysates were obtained by
incubation of 0.25 mg/ml lysozyme with the cell suspen-
sion in extraction buffer complemented with RNase and
DNase followed by brief sonication steps. The soluble
extract was isolated by centrifugation. SUMO-1 GST-
fusion protein and wild-type GST were purified on a Glu-
tathione Sepharose resin (GE Healthcare). Soluble
extracts were incubated for 3 hours at 4°C with 25 to 100
μl resin per milliliter of soluble extracts. Unbound pro-
teins were extensively washed away with a GST wash buf-
fer (PBS, 5% glycerol, 1% Triton X-100, 10 mM EDTA),
and TDG-N protein was eluted by digestion with Precis-
sion Protease using 25 μg/ml of resin (GE Healthcare) in
one bead volume of elution buffer (50 mM Tris-Cl pH 8.0,
150 mM NaCl, 2% glycerol, 0.1% NP-40, 10 mM EDTA, 5
mM DTT). The reaction was allowed to proceed at 4°C
for 20 hours. Then beads were eluted twice with one bead
volume of elution buffer. GST-SUMO-1 was eluted in one
bead volume of elution buffer (50 mM Tris-Cl pH 8.0, 200
mM NaCl, 5 mM EDTA, 5 mM DTT) containing 10 mM
of reduced (L)-glutathione and SUMO-1 was obtained by
an overnight incubation with 1 unit of thrombin per mg
Figure 4 Competition of SUMO-1 DNA interaction by TDG N-ter-
minus. GST-SUMO-1 DNA complexes were incubated with increasing 
amounts of free SUMO-1, the TDG N-terminus or GST for the UV-cross-
linking experiments carried out under the conditions described for Fig-
ure 3. The double stranded oligonucleotide used was the 65-mer. 
"Control" refers to the GST-SUMO-1 alone. Roughly 2 and 5 molar ex-
cess of competitor proteins were used.
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of protein at room temperature. Proteins were concen-
trated and purified by gel filtration on a preparative
Superdex75 column (GE Healthcare) equilibrated in
NMR sample buffer. Proteins were concentrated to obtain
final concentrations of 500 μM for SUMO-1. The protein
homogeneities were verified on denaturing polyacrylam-
ide gel, the molecular mass and isotopic labeling by
MALDI-TOF mass spectrometry.
NMR analysis of the interaction of SUMO-1 with dsDNA
For the DNA substrates, the sequences of the 5'-3' strands
are GAATTCGATAGGTTCC ACGGGTACTC-
GAAGCGGATCC and GATAGGTTCCACGGG-
TACTCGAAGC for the 37- and the 25-mer, respectively.
Annealing of oligonucleotides was performed by heating
1 mM solutions for 5 min at 100°C and cooling down the
mixtures slowly to room temperature to obtain double-
stranded 25-mers. These solutions were lyophilized and
dissolved at 50 μM final concentration. Interactions of
SUMO-1 with DNA was performed with the 25-mer dou-
ble-stranded DNA substrate with 20 μM of 15N-labeled
SUMO-1 and 135 μM DNA in a buffer constituted by 100
mM NaiPO4 pH 6.6, 1 mM DTT and 1 mM EDTA. 15N-
1H HSQC spectra were acquired for each condition with
1H and 15N spectral windows of 16 and 36.5 ppm, respec-
tively, and with 256 scans. The chemical shift perturba-
tions of individual resonances were calculated using the
following Eq 1.
DNA oligonucleotides, hybridization, DNase I digest
The sense sequence of the double-stranded oligonucle-
otides used was 5'-CGGAT CCCAA CTCCA GGAAG
GAAAC CAAGC GATTG GTTTC CTTCC TGGAG
TTGTT TTTCC CGGGT-3' (65-mer) and 5'-CGGGG
CCGGG GCGGG CCGCG CAAGC AG-3' (27-mer).
Each sense oligonucleotide was heated to 95°C for 10
minutes with equal amounts of the corresponding anti-
sense oligonucleotide and cooled down to 20°C within
one hour for appropriate hybridization.
DNase digest was performed using 1 Unit of DNase I
(Fermentas) incubating for 2 hours at 37°C prior to UV
crosslink.
UV crosslink, Competition
Approximately 100 ng of GST fusion protein was incu-
bated with increasing amounts (200 ng, 500 ng) of dou-
ble-stranded DNA for 10 minutes at 37°C in NMR buffer
(100 mM Na2PO4 pH 6.6, 1 mM EDTA, 1 mM DTT).
GST fusion protein alone was used as a control. The sam-
ple was cooled down immediately for 5 minutes on ice
and exposed to UV light for 10 minutes (TFX-20.M, 15
W, 312 nm). To check for effects of the UV crosslink to
the protein alone, non-crosslinked GST fusion protein
was used as a control.
To investigate DNA binding activity of SUMO-1 wild
type protein, approximately 100 ng of SUMO-1 was incu-
bated with increasing amounts (400 ng, 1000 ng) of dou-
ble-stranded DNA and treated as above-mentioned.
To analyze competition of DNA-binding, 100 ng of
GST-SUMO1 was incubated with 500 ng of double-
stranded DNA in presence of increasing amounts of wild
type SUMO1 or TDG-N-Terminus (200 ng, 400 ng) prior
to UV crosslink.
Western blot
Western blot analyses were performed as described pre-
viously [29] using mouse anti-GST antibody (Invitrogen)
and HRP-coupled goat anti-mouse antibody (Invitrogen)
as recommended by the manufacturer. For detection of
SUMO-1 a rabbit anti-SUMO-1 antibodiy(Pierce) and a
HRP-coupled goat anti-rabbit antibody (Cell Signaling)
was used as recommended by the manufacturer.
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